Professor Marc Ruitenberg
Group Leader
Professor Marc Ruitenberg is the Director of Biomedical Research at Mater Research. He also leads the Neuroimmunology Research Group, bringing internationally recognised leadership in neuroinflammation and central nervous system injury research.
His research career has been defined by challenging established concepts. His team has advanced understanding that inflammation following brain or spinal cord injury is not solely detrimental, but rather a process that can be reframed and modulated to promote repair.
This innovative approach has led to tangible translational outcomes. His work has already delivered real-world impact, with a world-first trial treating spinal cord injury, and he is currently working alongside Mater clinicians to develop a new diagnostic tool for autoimmune encephalitis.
His research career has been defined by challenging established concepts. His team has advanced understanding that inflammation following brain or spinal cord injury is not solely detrimental, but rather a process that can be reframed and modulated to promote repair.
This innovative approach has led to tangible translational outcomes. His work has already delivered real-world impact, with a world-first trial treating spinal cord injury, and he is currently working alongside Mater clinicians to develop a new diagnostic tool for autoimmune encephalitis.